Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer

Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer

Targeted drug delivery systems using nanocarriers offer a versatile platform for breast cancer treatment; however, a robust, CD44-targeted niosomal formulation has not been developed and deeply studied (both in vitro and in vivo) yet. Here, an optimized system of epirubicin (Epi)-loaded niosomal nan...

Full description

Bibliographic Details
Main Authors: Amirreza Mansoori-Kermani, Sadaf Khalighi, Iman Akbarzadeh, Fazeleh Ranjbar Niavol, Hamidreza Motasadizadeh, Athar Mahdieh, Vahid Jahed, Masoud Abdinezhad, Nikoo Rahbariasr, Mahshid Hosseini, Nima Ahmadkhani, Behnam Panahi, Yousef Fatahi, Masoud Mozafari, Alan Prem Kumar, Ebrahim Mostafavi
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Materials Today Bio
Subjects:
Nanomedicine
CD44
Active targeting
Breast cancer
Hyaluronic acid
Controlled drug delivery
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006422001478

Internet

http://www.sciencedirect.com/science/article/pii/S2590006422001478

Similar Items